1
|
Almarán B, Ramis G, Fernández de Mattos S, Villalonga P. Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma Cells Downstream of Receptor Tyrosine Kinase Signalling. Cells 2022; 11:cells11233716. [PMID: 36496976 PMCID: PMC9741382 DOI: 10.3390/cells11233716] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Revised: 11/09/2022] [Accepted: 11/16/2022] [Indexed: 11/23/2022] Open
Abstract
Enhanced invasiveness is one of the defining biological traits of glioblastoma cells, which exhibit an infiltrative nature that severely hinders surgical resection. Among the molecular lesions responsible for GBM aggressiveness, aberrant receptor tyrosine kinase (RTK) signalling is well-characterised. Enhanced RTK signalling directly impacts a myriad of cellular pathways and downstream effectors, which include the Rho GTPase family, key regulators of actin cytoskeletal dynamics. Here, we have analysed the functional crosstalk between oncogenic signals emanating from RTKs and Rho GTPases and focused on the specific contribution of Rnd3 to the invasive phenotype of GBM in this context. We found that RTK inhibition with a panel of RTK inhibitors decreased cell motility and cell invasion and promoted dramatic actin cytoskeleton reorganisation through activation of the RhoA/Rho-associated protein kinase 1 (ROCK) axis. RTK inhibition also significantly decreased Rnd3 expression levels. Consistently, shRNA-mediated Rnd3 silencing revealed that Rnd3 depletion promoted substantial changes in the actin cytoskeleton and reduced cell motility and invasion capacity, recapitulating the effects observed upon RTK inhibition. Our results indicate that Rnd3 is a crucial mediator of RTK oncogenic signalling involved in actin cytoskeletal reorganisation, which contributes to determining the invasive phenotype of GBM cells.
Collapse
Affiliation(s)
- Beatriz Almarán
- Cancer Cell Biology Laboratory, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Institut d’Investigació Sanitària Illes Balears (IdISBa), Universitat de les Illes Balears, 07122 Palma, Illes Balears, Spain
| | - Guillem Ramis
- Cancer Cell Biology Laboratory, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Institut d’Investigació Sanitària Illes Balears (IdISBa), Universitat de les Illes Balears, 07122 Palma, Illes Balears, Spain
- Serveis Científico-Tècnics, Universitat de les Illes Balears, 07122 Palma, Illes Balears, Spain
| | - Silvia Fernández de Mattos
- Cancer Cell Biology Laboratory, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Institut d’Investigació Sanitària Illes Balears (IdISBa), Universitat de les Illes Balears, 07122 Palma, Illes Balears, Spain
- Departament de Biologia Fonamental i Ciències de la Salut, Universitat de les Illes Balears, 07122 Palma, Illes Balears, Spain
| | - Priam Villalonga
- Cancer Cell Biology Laboratory, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Institut d’Investigació Sanitària Illes Balears (IdISBa), Universitat de les Illes Balears, 07122 Palma, Illes Balears, Spain
- Departament de Biologia Fonamental i Ciències de la Salut, Universitat de les Illes Balears, 07122 Palma, Illes Balears, Spain
- Correspondence: ; Tel.: +34-971-259961
| |
Collapse
|
2
|
Belayachi L, Aceves-Luquero C, Merghoub N, Bakri Y, Fernández de Mattos S, Amzazi S, Villalonga P. Editorial expression of concern: Retama monosperma n-hexane extract induces cell cycle arrest and extrinsic pathway-dependent apoptosis in jurkat cells. BMC Complement Med Ther 2022; 22:286. [PMID: 36333662 PMCID: PMC9636654 DOI: 10.1186/s12906-022-03771-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Affiliation(s)
- Lamiae Belayachi
- Cancer Cell Biology Group, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Edifici Cientificotècnic, Ctra Km 7,5, Valldemossa, Illes Balears, Palma de Mallorca, Spain ,Biochemistry Immunology Laboratory, Faculty of Sciences, Mohammed V-Agdal University, Rabat, Morocco
| | - Clara Aceves-Luquero
- Cancer Cell Biology Group, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Edifici Cientificotècnic, Ctra Km 7,5, Valldemossa, Illes Balears, Palma de Mallorca, Spain
| | - Nawel Merghoub
- Biochemistry Immunology Laboratory, Faculty of Sciences, Mohammed V-Agdal University, Rabat, Morocco
| | - Youssef Bakri
- Biochemistry Immunology Laboratory, Faculty of Sciences, Mohammed V-Agdal University, Rabat, Morocco
| | - Silvia Fernández de Mattos
- Cancer Cell Biology Group, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Edifici Cientificotècnic, Ctra Km 7,5, Valldemossa, Illes Balears, Palma de Mallorca, Spain ,grid.9563.90000 0001 1940 4767Departament de Biologia Fonamental, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Edifici Cientificotècnic, Ctra Km 7,5, Valldemossa, Illes Balears, Palma de Mallorca, Spain
| | - Saaïd Amzazi
- Biochemistry Immunology Laboratory, Faculty of Sciences, Mohammed V-Agdal University, Rabat, Morocco
| | - Priam Villalonga
- Cancer Cell Biology Group, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Edifici Cientificotècnic, Ctra Km 7,5, Valldemossa, Illes Balears, Palma de Mallorca, Spain ,grid.9563.90000 0001 1940 4767Departament de Biologia Fonamental, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Edifici Cientificotècnic, Ctra Km 7,5, Valldemossa, Illes Balears, Palma de Mallorca, Spain
| |
Collapse
|
3
|
Galiana-Roselló C, Aceves-Luquero C, González J, Martínez-Camarena Á, Villalonga R, Fernández de Mattos S, Soriano C, Llinares J, García-España E, Villalonga P, González-Rosende ME. Toward a Rational Design of Polyamine-Based Zinc-Chelating Agents for Cancer Therapies. J Med Chem 2020; 63:1199-1215. [PMID: 31935092 DOI: 10.1021/acs.jmedchem.9b01554] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
In vitro viability assays against a representative panel of human cancer cell lines revealed that polyamines L1a and L5a displayed remarkable activity with IC50 values in the micromolar range. Preliminary research indicated that both compounds promoted G1 cell cycle arrest followed by cellular senescence and apoptosis. The induction of apoptotic cell death involved loss of mitochondrial outer membrane permeability and activation of caspases 3/7. Interestingly, L1a and L5a failed to activate cellular DNA damage response. The high intracellular zinc-chelating capacity of both compounds, deduced from the metal-specific Zinquin assay and ZnL2+ stability constant values in solution, strongly supports their cytotoxicity. These data along with quantum mechanical studies have enabled to establish a precise structure-activity relationship. Moreover, L1a and L5a showed appropriate drug-likeness by in silico methods. Based on these promising results, L1a and L5a should be considered a new class of zinc-chelating anticancer agents that deserves further development.
Collapse
Affiliation(s)
- Cristina Galiana-Roselló
- Instituto de Ciencia Molecular (ICMol), Departamento de Química Inorgánica , Universidad de Valencia , Paterna, 46980 Valencia , Spain.,Departamento de Farmacia, Facultad de Ciencias de la Salud , Universidad CEU Cardenal Herrera, C/ Ramón y Cajal, s/n , Alfara del Patriarca, 46115 Valencia , Spain
| | - Clara Aceves-Luquero
- Cancer Cell Biology Laboratory, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS) , Universitat de les Illes Balears, and Institut d'Investigació Sanitària Illes Balears (IdISBa) , Palma, 07122 Illes Balears , Spain
| | - Jorge González
- Instituto de Ciencia Molecular (ICMol), Departamento de Química Inorgánica , Universidad de Valencia , Paterna, 46980 Valencia , Spain
| | - Álvaro Martínez-Camarena
- Instituto de Ciencia Molecular (ICMol), Departamento de Química Inorgánica , Universidad de Valencia , Paterna, 46980 Valencia , Spain
| | - Ruth Villalonga
- Departament de Química , Universitat de les llles Balears , Palma, 07122 Illes Balears , Spain
| | - Silvia Fernández de Mattos
- Cancer Cell Biology Laboratory, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS) , Universitat de les Illes Balears, and Institut d'Investigació Sanitària Illes Balears (IdISBa) , Palma, 07122 Illes Balears , Spain.,Departament de Biologia Fonamental , Universitat de les Illes Balears , Palma, 07122 Illes Balears , Spain
| | - Concepción Soriano
- Departamento de Química Orgánica , Universidad de Valencia , C/Dr. Moliner s/n , Burjassot, 46100 Valencia , Spain
| | - José Llinares
- Departamento de Química Orgánica , Universidad de Valencia , C/Dr. Moliner s/n , Burjassot, 46100 Valencia , Spain
| | - Enrique García-España
- Instituto de Ciencia Molecular (ICMol), Departamento de Química Inorgánica , Universidad de Valencia , Paterna, 46980 Valencia , Spain
| | - Priam Villalonga
- Cancer Cell Biology Laboratory, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS) , Universitat de les Illes Balears, and Institut d'Investigació Sanitària Illes Balears (IdISBa) , Palma, 07122 Illes Balears , Spain
| | - María Eugenia González-Rosende
- Departamento de Farmacia, Facultad de Ciencias de la Salud , Universidad CEU Cardenal Herrera, C/ Ramón y Cajal, s/n , Alfara del Patriarca, 46115 Valencia , Spain
| |
Collapse
|
4
|
Belayachi L, Aceves-Luquero C, Merghoub N, de Mattos SF, Amzazi S, Villalonga P, Bakri Y. INDUCTION OF CELL CYCLE ARREST AND APOPTOSIS BY ORMENIS ERIOLEPIS A MORROCAN ENDEMIC PLANT IN VARIOUS HUMAN CANCER CELL LINES. Afr J Tradit Complement Altern Med 2017; 14:356-373. [PMID: 28573252 PMCID: PMC5446462 DOI: 10.21010/ajtcam.v14i2.37] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Background: Ormenis eriolepis Coss (Asteraceae) is an endemic Moroccan subspecies, traditionally named “Hellala” or “Fergoga”. It’s usually used for its hypoglycemic effect as well as for the treatment of stomacal pain. As far as we know, there is no scientific exploration of anti tumoral activity of Ormenis eriolepis extracts. Materials and Methods: In this regard, we performed a screening of organic extracts and fractions in a panel of both hematological and solid cancer cell lines, to evaluate the potential in vitro anti tumoral activity and to elucidate the respective mechanisms that may be responsible for growth arrest and cell death induction. The plant was extracted using organic solvents, and four different extracts were screened on Jurkat, Jeko-1, TK-6, LN229, SW620, U2OS, PC-3 and NIH3T3 cells. Results: Cell viability assays revealed that, the IC50 values were (11,63±5,37μg/ml) for Jurkat, (13,33±1,67μg/ml) for Jeko-1, (41,67±1,98μg/ml) for LN229 and (19,31±4,88μg/ml) for PC-3 cells upon treatment with Oe-DF and Oe-HE respectively. Both the fraction and extract exhibited no effects on TK6 and NIH3T3. Cytometry analysis accompanied by DNA damage signaling protein levels monitoring (p-H2A.X), showed that both the Dichloromethane Fraction and Hexanic extract induce DNA double stranded breaks (DSBs) accompanied by cell cycle arrest in G1 (Jurkat, Jeko -1 and LN22) and G2/M (PC-3) phases which is agreed with the caspase activity observed. Additional experiments with selective inhibitors of stress and survival pathways (JNK, MAPK, Rho, p53, and JAK3) indicated that none of these pathways was significantly involved in apoptosis induction. The bioactive compound analysis by CG/MS indicated that the major compounds in Oe-DF were: Linoleic Acid (15,89%), Podophyllotoxin (17,89%) and Quercetin (22,95%). For Oe-HE the major molecules were: Linoleic Acid (9,76%), α-curcumene (7,07%), α-bisabolol (5,49%), Campesterol (4,41%), Stigmasterol (14,08%) and β-sitosterol (7,49%). Conclusion: Our data suggest that bioactive compounds present in Ormenis eriolepis show significant anti proliferative activity inducing cell cycle arrest and cell death operating through apoptosis pathway.
Collapse
Affiliation(s)
- Lamiae Belayachi
- Biochemistry, Immunology Laboratory, Faculty of Sciences, Mohammed V-Agdal University, Rabat, Morocco.,Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Rabat - Morocco
| | - Clara Aceves-Luquero
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Rabat - Morocco
| | - Nawel Merghoub
- MAScIR (Moroccan Foundation for Advanced Science, Innovation & Research)- Rabat Design Center, Rabat - Morocco
| | - Silvia Fernández de Mattos
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Rabat - Morocco.,Departament de Biologia Fonamental, Universitat de les Illes Balears, Illes Balears, Spain, Green Biotechnology Center, Rabat - Morocco
| | - Saaîd Amzazi
- Biochemistry, Immunology Laboratory, Faculty of Sciences, Mohammed V-Agdal University, Rabat, Morocco
| | - Priam Villalonga
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Rabat - Morocco.,Departament de Biologia Fonamental, Universitat de les Illes Balears, Illes Balears, Spain, Green Biotechnology Center, Rabat - Morocco
| | - Youssef Bakri
- Biochemistry, Immunology Laboratory, Faculty of Sciences, Mohammed V-Agdal University, Rabat, Morocco
| |
Collapse
|
5
|
Aceves-Luquero C, Galiana-Roselló C, Ramis G, Villalonga-Planells R, García-España E, Fernández de Mattos S, Peláez R, Llinares JM, González-Rosende ME, Villalonga P. N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility. Biochem Pharmacol 2016; 115:28-42. [PMID: 27349984 DOI: 10.1016/j.bcp.2016.06.016] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2016] [Accepted: 06/23/2016] [Indexed: 10/21/2022]
Abstract
A series of compounds containing the sulfonamide scaffold were synthesized and screened for their in vitro anticancer activity against a representative panel of human cancer cell lines, leading to the identification of N-(2-methyl-1H-indol-5-yl)-1-naphthalenesulfonamide (8e) as a compound showing a remarkable activity across the panel, with IC50 values in the nanomolar-to-low micromolar range. Cell cycle distribution analysis revealed that 8e promoted a severe G2/M arrest, which was followed by cellular senescence as indicated by the detection of senescence-associated β-galactosidase (SA-β-gal) in 8e-treated cells. Prolonged 8e treatment also led to the onset of apoptosis, in correlation with the detection of increased Caspase 3/7 activities. Despite increasing γ-H2A.X levels, a well-established readout for DNA double-strand breaks, in vitro DNA binding studies with 8e did not support interaction with DNA. In agreement with this, 8e failed to activate the cellular DNA damage checkpoint. Importantly, tubulin staining showed that 8e promoted a severe disorganization of microtubules and mitotic spindle formation was not detected in 8e-treated cells. Accordingly, 8e inhibited tubulin polymerization in vitro in a dose-dependent manner and was also able to robustly inhibit cancer cell motility. Docking analysis revealed a compatible interaction with the colchicine-binding site of tubulin. Remarkably, these cellular effects were reversible since disruption of treatment resulted in the reorganization of microtubules, cell cycle re-entry and loss of senescent markers. Collectively, our data suggest that this compound may be a promising new anticancer agent capable of both reducing cancer cell growth and motility.
Collapse
Affiliation(s)
- Clara Aceves-Luquero
- Cancer Cell Biology Laboratory, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les llles Balears, Palma, Illes Balears, Spain; Institut d'Investigació Sanitària de Palma (IdISPa), Palma, Illes Balears, Spain
| | - Cristina Galiana-Roselló
- Departamento de Farmacia, Universidad CEU-Cardenal Herrera, Moncada, Valencia, Spain; Departamento de Química Orgánica, ICMoL, Universitat de València, Paterna, Spain
| | - Guillem Ramis
- Cancer Cell Biology Laboratory, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les llles Balears, Palma, Illes Balears, Spain; Institut d'Investigació Sanitària de Palma (IdISPa), Palma, Illes Balears, Spain
| | | | | | - Silvia Fernández de Mattos
- Cancer Cell Biology Laboratory, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les llles Balears, Palma, Illes Balears, Spain; Departament de Biologia Fonamental i Ciències de la Salut, Universitat de les llles Balears, Palma, Illes Balears, Spain; Institut d'Investigació Sanitària de Palma (IdISPa), Palma, Illes Balears, Spain
| | - Rafael Peláez
- Departamento de Química Farmacéutica, Universidad de Salamanca, Salamanca, Spain
| | - José M Llinares
- Departamento de Química Orgánica, ICMoL, Universitat de València, Paterna, Spain
| | | | - Priam Villalonga
- Cancer Cell Biology Laboratory, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les llles Balears, Palma, Illes Balears, Spain; Departament de Biologia Fonamental i Ciències de la Salut, Universitat de les llles Balears, Palma, Illes Balears, Spain; Institut d'Investigació Sanitària de Palma (IdISPa), Palma, Illes Balears, Spain.
| |
Collapse
|
6
|
Obrador-Hevia A, Serra-Sitjar M, Rodríguez J, Belayachi L, Bento L, García-Recio M, Sánchez JM, Villalonga P, Gutiérrez A, Fernández de Mattos S. Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma. Br J Haematol 2016; 174:899-910. [DOI: 10.1111/bjh.14141] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2015] [Accepted: 03/20/2016] [Indexed: 11/26/2022]
Affiliation(s)
- Antònia Obrador-Hevia
- Cancer Cell Biology Group; Institut Universitari d'Investigació en Ciències de La Salut (IUNICS); Palma Illes Balears Spain
- Departament de Biologia Fonamental; Universitat de les Illes Balears; Palma Illes Balears Spain
- Institut de Investigació Sanitària de Palma (IdISPa); Palma Illes Balears Spain
| | - Margalida Serra-Sitjar
- Cancer Cell Biology Group; Institut Universitari d'Investigació en Ciències de La Salut (IUNICS); Palma Illes Balears Spain
- Institut de Investigació Sanitària de Palma (IdISPa); Palma Illes Balears Spain
| | | | - Lamiae Belayachi
- Cancer Cell Biology Group; Institut Universitari d'Investigació en Ciències de La Salut (IUNICS); Palma Illes Balears Spain
| | - Leyre Bento
- Institut de Investigació Sanitària de Palma (IdISPa); Palma Illes Balears Spain
- Service of Hematology; Son Espases University Hospital; Palma Illes Balears Spain
| | - Marta García-Recio
- Service of Hematology; Son Espases University Hospital; Palma Illes Balears Spain
| | - Jose María Sánchez
- Institut de Investigació Sanitària de Palma (IdISPa); Palma Illes Balears Spain
- Service of Hematology; Son Espases University Hospital; Palma Illes Balears Spain
| | - Priam Villalonga
- Cancer Cell Biology Group; Institut Universitari d'Investigació en Ciències de La Salut (IUNICS); Palma Illes Balears Spain
- Departament de Biologia Fonamental; Universitat de les Illes Balears; Palma Illes Balears Spain
- Institut de Investigació Sanitària de Palma (IdISPa); Palma Illes Balears Spain
| | - Antonio Gutiérrez
- Institut de Investigació Sanitària de Palma (IdISPa); Palma Illes Balears Spain
- Service of Hematology; Son Espases University Hospital; Palma Illes Balears Spain
| | - Silvia Fernández de Mattos
- Cancer Cell Biology Group; Institut Universitari d'Investigació en Ciències de La Salut (IUNICS); Palma Illes Balears Spain
- Departament de Biologia Fonamental; Universitat de les Illes Balears; Palma Illes Balears Spain
- Institut de Investigació Sanitària de Palma (IdISPa); Palma Illes Balears Spain
| |
Collapse
|
7
|
González-Bártulos M, Aceves-Luquero C, Qualai J, Cussó O, Martínez MA, Fernández de Mattos S, Menéndez JA, Villalonga P, Costas M, Ribas X, Massaguer A. Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells. PLoS One 2015; 10:e0137800. [PMID: 26368127 PMCID: PMC4569415 DOI: 10.1371/journal.pone.0137800] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2015] [Accepted: 08/21/2015] [Indexed: 12/22/2022] Open
Abstract
Differential redox homeostasis in normal and malignant cells suggests that pro-oxidant-induced upregulation of cellular reactive oxygen species (ROS) should selectively target cancer cells without compromising the viability of untransformed cells. Consequently, a pro-oxidant deviation well-tolerated by nonmalignant cells might rapidly reach a cell-death threshold in malignant cells already at a high setpoint of constitutive oxidative stress. To test this hypothesis, we took advantage of a selected number of amine-pyridine-based Fe(II) complexes that operate as efficient and robust oxidation catalysts of organic substrates upon reaction with peroxides. Five of these Fe(II)-complexes and the corresponding aminopyridine ligands were selected to evaluate their anticancer properties. We found that the iron complexes failed to display any relevant activity, while the corresponding ligands exhibited significant antiproliferative activity. Among the ligands, none of which were hemolytic, compounds 1, 2 and 5 were cytotoxic in the low micromolar range against a panel of molecularly diverse human cancer cell lines. Importantly, the cytotoxic activity profile of some compounds remained unaltered in epithelial-to-mesenchymal (EMT)-induced stable populations of cancer stem-like cells, which acquired resistance to the well-known ROS inducer doxorubicin. Compounds 1, 2 and 5 inhibited the clonogenicity of cancer cells and induced apoptotic cell death accompanied by caspase 3/7 activation. Flow cytometry analyses indicated that ligands were strong inducers of oxidative stress, leading to a 7-fold increase in intracellular ROS levels. ROS induction was associated with their ability to bind intracellular iron and generate active coordination complexes inside of cells. In contrast, extracellular complexation of iron inhibited the activity of the ligands. Iron complexes showed a high proficiency to cleave DNA through oxidative-dependent mechanisms, suggesting a likely mechanism of cytotoxicity. In summary, we report that, upon chelation of intracellular iron, the pro-oxidant activity of amine-pyrimidine-based iron complexes efficiently kills cancer and cancer stem-like cells, thus providing functional evidence for an efficient family of redox-directed anti-cancer metallodrugs.
Collapse
Affiliation(s)
- Marta González-Bártulos
- Department of Biology, University of Girona, Girona, Catalunya, Spain
- Institut de Química Computacional i Catàlisi (IQCC), University of Girona, Girona, Catalunya, Spain
| | - Clara Aceves-Luquero
- Departament de Biologia Fonamental and Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
| | - Jamal Qualai
- Department of Chemistry, University of Girona, Girona, Catalunya, Spain
| | - Olaf Cussó
- Department of Chemistry, University of Girona, Girona, Catalunya, Spain
- Institut de Química Computacional i Catàlisi (IQCC), University of Girona, Girona, Catalunya, Spain
| | - Mª Angeles Martínez
- Department of Biology, University of Girona, Girona, Catalunya, Spain
- Department of Chemistry, University of Girona, Girona, Catalunya, Spain
| | - Silvia Fernández de Mattos
- Departament de Biologia Fonamental and Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
| | - Javier A. Menéndez
- Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Catalunya, Spain
- Girona Biomedical Research Institute (IDIBGI), Girona, Catalunya, Spain
- * E-mail: (AM); (XR); (MC); (JAM)
| | - Priam Villalonga
- Departament de Biologia Fonamental and Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
| | - Miquel Costas
- Department of Chemistry, University of Girona, Girona, Catalunya, Spain
- Institut de Química Computacional i Catàlisi (IQCC), University of Girona, Girona, Catalunya, Spain
- * E-mail: (AM); (XR); (MC); (JAM)
| | - Xavi Ribas
- Department of Chemistry, University of Girona, Girona, Catalunya, Spain
- Institut de Química Computacional i Catàlisi (IQCC), University of Girona, Girona, Catalunya, Spain
- * E-mail: (AM); (XR); (MC); (JAM)
| | - Anna Massaguer
- Department of Biology, University of Girona, Girona, Catalunya, Spain
- * E-mail: (AM); (XR); (MC); (JAM)
| |
Collapse
|
8
|
Sampedro A, Villalonga-Planells R, Vega M, Ramis G, Fernández de Mattos S, Villalonga P, Costa A, Rotger C. Cell uptake and localization studies of squaramide based fluorescent probes. Bioconjug Chem 2014; 25:1537-46. [PMID: 25036647 DOI: 10.1021/bc500258b] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Cell internalization is a major issue in drug design. Although squaramide-based compounds are receiving much attention because of their interesting bioactivity, cell uptake and trafficking within cells of this type of compounds are still unknown. In order to monitor the cell internalization process of cyclosquaramide compounds we have prepared two fluorescent probes by covalently linking a fluorescent dye (BODIPY derivative or fluorescein) to a noncytotoxic cyclosquaramide framework. These two probes (C2-BDP and C2-FITC) rapidly internalize across live cell membranes through endocytic receptor-mediated mechanisms. Due to its higher fluorescence and photochemical stability, C2-BDP is a superior dye than C2-FITC. C2-BDP remains sequestered in late endosomes allowing their fast and selective imaging in various live cell types. Cyclosquaramide-cell membrane interactions facilitate cell uptake and have been investigated by binding studies in solution as well as in live cells. Cyclosquaramide 1 (C2-BDP) can be used as a highly fluorescent probe for the rapid and selective imaging of late endosomes in live cells.
Collapse
Affiliation(s)
- Angel Sampedro
- Departament de Química, ‡Departament de Biologia Fonamental, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS) and Instituto de Investigación Sanitaria de Palma (IdISPa), Illes Balears, Spain, Universitat de les Illes Balears , Ctra. Valldemossa km 7.5, 07122 Palma, Spain
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Belayachi L, Aceves-Luquero C, Merghoub N, Bakri Y, Fernández de Mattos S, Amzazi S, Villalonga P. Retama monosperma n-hexane extract induces cell cycle arrest and extrinsic pathway-dependent apoptosis in Jurkat cells. Altern Ther Health Med 2014; 14:38. [PMID: 24460687 PMCID: PMC3916308 DOI: 10.1186/1472-6882-14-38] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2013] [Accepted: 01/14/2014] [Indexed: 11/10/2022]
Abstract
BACKGROUND Retama monosperma L. (Boiss.) or Genista monosperma L. (Lam.), locally named as "R'tam", is an annual and spontaneous plant belonging to the Fabaceae family. In Morocco, Retama genus is located in desert regions and across the Middle Atlas and it has been widely used in traditional medicine in many countries. In this study, we show that Retama monosperma hexane extract presents significant anti-leukemic effects against human Jurkat cells. METHODS Human Jurkat cells, together with other cell lines were screened with different concentrations of Retama monosperma hexane extract at different time intervals. Growth inhibition was determined using luminescent-based viability assays. Cell cycle arrest and apoptosis were measured by flow cytometry analysis. Combined caspase 3 and 7 activities were measured using luminometric caspase assays and immunoblots were performed to analyze expression of relevant pro- and anti-apoptotic proteins. GC-MS were used to determine the chemical constituents of the active extract. RESULTS Retama monosperma hexane extract (Rm-HE) showed significant cytotoxicity against Jurkat cells, whereas it proved to be essentially ineffective against both normal mouse fibroblasts (NIH3T3) and normal lymphocytes (TK-6). Cytometric analysis indicated that Rm-HE promoted cell cycle arrest and apoptosis induction accompanied by DNA damage induction indicated by an increase in p-H2A.X levels. Rm-HE induced apoptosis was partially JNK-dependent and characterized by an increase in Fas-L levels together with activation of caspases 8, 3, 7 and 9, whereas neither the pro-apoptotic nor anti-apoptotic mitochondrial membrane proteins analyzed were significantly altered. Chemical identification analysis indicated that α-linolenic acid, campesterol, stigmasterol and sitosterol were the major bioactive components within the extract. CONCLUSIONS Our data suggest that bioactive compounds present in Rm-HE show significant anti leukemic activity inducing cell cycle arrest and cell death that operates, at least partially, through the extrinsic apoptosis pathway.
Collapse
|
10
|
Villalonga P, Fernández de Mattos S, Ramis G, Obrador-Hevia A, Sampedro A, Rotger C, Costa A. Cyclosquaramides as Kinase Inhibitors with Anticancer Activity. ChemMedChem 2012; 7:1472-80. [DOI: 10.1002/cmdc.201200157] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2012] [Revised: 06/15/2012] [Indexed: 11/11/2022]
|
11
|
Ramis G, Thomàs-Moyà E, Fernández de Mattos S, Rodríguez J, Villalonga P. EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth. PLoS One 2012; 7:e38770. [PMID: 22701710 PMCID: PMC3368887 DOI: 10.1371/journal.pone.0038770] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2012] [Accepted: 05/13/2012] [Indexed: 12/30/2022] Open
Abstract
Enforced EGFR activation upon gene amplification and/or mutation is a common hallmark of malignant glioma. Small molecule EGFR tyrosine kinase inhibitors, such as erlotinib (Tarceva), have shown some activity in a subset of glioma patients in recent trials, although the reported data on the cellular basis of glioma cell responsiveness to these compounds have been contradictory. Here we have used a panel of human glioma cell lines, including cells with amplified or mutant EGFR, to further characterize the cellular effects of EGFR inhibition with erlotinib. Dose-response and cellular growth assays indicate that erlotinib reduces cell proliferation in all tested cell lines without inducing cytotoxic effects. Flow cytometric analyses confirm that EGFR inhibition does not induce apoptosis in glioma cells, leading to cell cycle arrest in G1. Interestingly, erlotinib also prevents spontaneous multicellular tumour spheroid growth in U87MG cells and cooperates with sub-optimal doses of temozolomide (TMZ) to reduce multicellular tumour spheroid growth. This cooperation appears to be schedule-dependent, since pre-treatment with erlotinib protects against TMZ-induced cytotoxicity whereas concomitant treatment results in a cooperative effect. Cell cycle arrest in erlotinib-treated cells is associated with an inhibition of ERK and Akt signaling, resulting in cyclin D1 downregulation, an increase in p27kip1 levels and pRB hypophosphorylation. Interestingly, EGFR inhibition also perturbs Rho GTPase signaling and cellular morphology, leading to Rho/ROCK-dependent formation of actin stress fibres and the inhibition of glioma cell motility and invasion.
Collapse
Affiliation(s)
- Guillem Ramis
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
| | - Elena Thomàs-Moyà
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
| | - Silvia Fernández de Mattos
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
- Departament de Biologia Fonamental, Universitat de les Illes Balears, Illes Balears, Spain
| | - José Rodríguez
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
| | - Priam Villalonga
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Illes Balears, Spain
- Departament de Biologia Fonamental, Universitat de les Illes Balears, Illes Balears, Spain
- * E-mail:
| |
Collapse
|
12
|
Obrador-Hevia A, Serra-Sitjar M, Rodríguez J, Villalonga P, Fernández de Mattos S. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival. Br J Haematol 2011; 156:334-45. [PMID: 22107151 DOI: 10.1111/j.1365-2141.2011.08951.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
The FOXO3 (Forkhead/winged helix box class O 3) transcription factor is a crucial regulator of haematopoietic cell fate that controls proliferation and apoptosis, among other processes. Despite the central role of FOXO3 as a tumour suppressor and phosphatidylinositol 3-kinase (PI3K)/AKT effector, little is known about its involvement in mantle cell lymphoma (MCL) biology. This study investigated the expression and activity of FOXO3 in MCL cell lines and in primary cultures. We analysed the expression of key FOXO regulators and targets, and studied the effect of modulators of FOXO function on cell viability and apoptosis. FOXO3 was constitutively inactivated in MCL cell lines, and showed cytoplasmic localization in patient-derived cells. PI3K and AKT, but not mammalian target of rapamycin (mTOR), inhibitors induced FOXO3 nuclear translocation and activation in correlation with their impact on MCL proliferation and survival. Moreover, FOXO3-defective cells were resistant to PI3K/AKT inhibitors. Reactivation of FOXO function with a nuclear export inhibitor had a profound effect on cell viability, consistent with FOXO3 nuclear accumulation. Interestingly, inhibition of FOXO3 nuclear export enhanced the effect of doxorubicin. Taken together, our results confirm that FOXO3 is a relevant regulator of proliferation and apoptosis in MCL, and suggest that reactivation of FOXO3 function might be a useful therapeutic strategy in MCL patients.
Collapse
Affiliation(s)
- Antònia Obrador-Hevia
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears, Palma, Illes Balears, Crta Valldemossa km 7Æ5. E-07122 Palma, Illes Balears, Spain
| | | | | | | | | |
Collapse
|
13
|
|
14
|
Obrador A, Villalonga P, Rodríguez J, Fernández de Mattos S. 740 Role of the tumour suppressor FOXO3a and its regulation by β-catenin in the pathogenesis of non-Hodgkin's Lymphomas. EJC Suppl 2010. [DOI: 10.1016/s1359-6349(10)71537-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
15
|
Villalonga P, Fernández de Mattos S, Ridley AJ. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation. J Biol Chem 2010; 284:35287-96. [PMID: 19850923 DOI: 10.1074/jbc.m109.050120] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The Rho GTPase family member RhoE inhibits RhoA/ROCK signaling to promote actin stress fiber and focal adhesion disassembly. We have previously reported that RhoE also inhibits cell cycle progression and Ras-induced transformation, specifically preventing cyclin D1 translation. Here we investigate the molecular mechanisms underlying those observations. RhoE inhibits the phosphorylation of the translational repressor 4E-BP1 in response to extracellular stimuli. However, RhoE does not affect the activation of mTOR, the major kinase regulating 4E-BP1 phosphorylation, as indicated by the phosphorylation levels of the mTOR substrate S6K, the dynamics of mTOR/Raptor association, and the observation that RhoE, as opposed to rapamycin, does not impair cellular growth. Interestingly, RhoE prevents the release of the eukaryotic initiation factor eIF4E from 4E-BP1, inhibiting cap-dependent translation. Accordingly, RhoE also inhibits the expression and the transcriptional activity of the eIF4E target c-Myc. Consistent with its crucial role in cell proliferation, we show that eIF4E can rescue both cell cycle progression and Ras-induced transformation in RhoE-expressing cells, indicating that the inhibition of eIF4E function is critical to mediate the anti-proliferative effects of RhoE.
Collapse
Affiliation(s)
- Priam Villalonga
- Ludwig Institute for Cancer Research, University College London, W1W7BS London, United Kingdom.
| | | | | |
Collapse
|
16
|
Fernández de Mattos S, Villalonga P, Clardy J, Lam EWF. FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol Cancer Ther 2008; 7:3237-46. [PMID: 18852127 DOI: 10.1158/1535-7163.mct-08-0398] [Citation(s) in RCA: 106] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Cisplatin is a conventional chemotherapeutic agent that binds covalently to purine DNA bases and mediates cellular apoptosis. A better understanding of the downstream cellular targets of cisplatin will provide information on its mechanism of action and help to understand the mechanism of drug resistance. In this study, we have investigated the effects of cisplatin in a panel of colon carcinoma cell lines and the involvement of the phosphoinositide-3-kinase/forkhead/winged helix box class O (FOXO) pathway in cisplatin action and resistance. Cisplatin-sensitive and cisplatin-resistant cell lines have been characterized in cell viability, flow cytometry, and clonogenic assays. The main components of the phosphoinositide-3-kinase/protein kinase B pathway, particularly FOXO3a, have been analyzed in sensitive and resistant cells on cisplatin treatment. Interestingly, in sensitive cells, cisplatin induces FOXO3a dephosphorylation and nuclear translocation, and expression of its target genes, whereas in resistant cells the effect of cisplatin on FOXO3a is incomplete. Consistent with this, protein kinase B/FOXO signaling axis modulators triciribine and psammaplysene A sensitize the resistant HT29 cells to cisplatin treatment. Critically, knockdown of FOXO3a expression using small interfering RNA rescues sensitive SW620 cells from cisplatin-induced short- and long-term cell death. Together, our findings suggest that FOXO3a is a relevant mediator of the cytotoxic effects of cisplatin in colon cancer cells.
Collapse
Affiliation(s)
- Silvia Fernández de Mattos
- Cancer Cell Biology Group, Institut Universitari d'Investigació en Ciències de la Salut, Departament de Biologia Fonamental, Universitat de les Illes Balears, Crta Valldemossa km 7.5, E-07122 Palma, Illes Balears, Spain.
| | | | | | | |
Collapse
|
17
|
Lopez-Alcalá C, Alvarez-Moya B, Villalonga P, Calvo M, Bachs O, Agell N. Identification of Essential Interacting Elements in K-Ras/Calmodulin Binding and Its Role in K-Ras Localization. J Biol Chem 2008; 283:10621-31. [DOI: 10.1074/jbc.m706238200] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
|
18
|
Abstract
Members of the Rho family of small GTPases are crucial regulators of biological responses in eukaryotic cells, including cytoskeletal dynamics, cell motility and cell cycle progression. In the present review, we summarize our current understanding of the role of Rho proteins in cell cycle control, highlighting the contribution of specific members of the Rho family and their downstream targets to the regulation of key elements from the core cell cycle machinery, mostly involved in the G1/S transition.
Collapse
Affiliation(s)
- Priam Villalonga
- Ludwig Institute for Cancer Research and Department of Biochemistry and Molecular Biology, University College London, London, UK
| | | |
Collapse
|
19
|
Abstract
The three Rnd proteins, Rnd1, Rnd2 and RhoE/Rnd3, are a subset of Rho family proteins that are unusual in that they bind but do not hydrolyse GTP, and are therefore not regulated by the classical GTP/GDP conformational switch of small GTPases. Increased expression of each Rnd protein induces loss of stress fibres in cultured fibroblasts and epithelial cells, acting antagonistically to RhoA, which stimulates stress fibre formation. RhoE is farnesylated and localizes partly on membranes, including the Golgi and plasma membrane, and in the cytosol. RhoE inhibits RhoA signalling in part by binding to the RhoA-activated serine/threonine kinase ROCK I (Rho-associated kinase I), thereby preventing it from phosphorylating its targets. RhoE activity is itself regulated by phosphorylation by ROCK I on multiple sites. RhoE phosphorylation enhances its stability, leading to an increase in RhoE levels. In addition, phosphorylation reduces its association with membranes and correlates with its ability to induce loss of stress fibres. RhoE also acts independently of ROCK to inhibit cell cycle progression, in part by preventing translation of cyclin D1, and to inhibit transformation of fibroblasts by oncogenic H-Ras. RhoE is therefore a multifunctional protein whose localization and actions are regulated by phosphorylation.
Collapse
Affiliation(s)
- K Riento
- Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, 91 Riding House Street, London W1W 7BS, UK
| | | | | | | |
Collapse
|
20
|
Riento K, Totty N, Villalonga P, Garg R, Guasch R, Ridley AJ. RhoE function is regulated by ROCK I-mediated phosphorylation. EMBO J 2005; 24:1170-80. [PMID: 15775972 PMCID: PMC556412 DOI: 10.1038/sj.emboj.7600612] [Citation(s) in RCA: 131] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2004] [Accepted: 02/10/2005] [Indexed: 01/03/2023] Open
Abstract
The Rho GTPase family member RhoE regulates actin filaments partly by binding to and inhibiting ROCK I, a serine/threonine kinase that induces actomyosin contractility. Here, we show that ROCK I can phosphorylate multiple residues on RhoE in vitro. In cells, ROCK I-phosphorylated RhoE localizes in the cytosol, whereas unphosphorylated RhoE is primarily associated with membranes. Phosphorylation has no effect on RhoE binding to ROCK I, but instead increases RhoE protein stability. Using phospho-specific antibodies, we show that ROCK phosphorylates endogenous RhoE at serine 11 upon cell stimulation with platelet-derived growth factor, and that this phosphorylation requires an active protein kinase C signalling pathway. In addition, we demonstrate that phosphorylation of RhoE correlates with its activity in inducing stress fibre disruption and inhibiting Ras-induced transformation. This is the first demonstration of an endogenous Rho family member being phosphorylated in vivo and indicates that phosphorylation is an important mechanism to control the stability and function of this GTPase-deficient Rho protein.
Collapse
Affiliation(s)
- Kirsi Riento
- Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, London, UK
| | - Nick Totty
- Cancer Research UK, London Research Institute, Lincoln's Inn Fields, London, UK
| | - Priam Villalonga
- Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, London, UK
| | - Ritu Garg
- Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, London, UK
| | - Rosa Guasch
- Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, London, UK
| | - Anne J Ridley
- Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, London, UK
- Department of Biochemistry and Molecular Biology, University College London, London, UK
- Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, 91 Riding House Street, London W1W 7BS, UK. Tel.: +44 20 7878 4033; Fax: +44 20 7878 4040; E-mail:
| |
Collapse
|
21
|
Abstract
Rho GTPases are major regulators of cytoskeletal dynamics, but they also affect cell proliferation, transformation, and oncogenesis. RhoE, a member of the Rnd subfamily that does not detectably hydrolyze GTP, inhibits RhoA/ROCK signaling to promote actin stress fiber and focal adhesion disassembly. We have generated fibroblasts with inducible RhoE expression to investigate the role of RhoE in cell proliferation. RhoE expression induced a loss of stress fibers and cell rounding, but these effects were only transient. RhoE induction inhibited cell proliferation and serum-induced S-phase entry. Neither ROCK nor RhoA inhibition accounted for this response. Consistent with its inhibitory effect on cell cycle progression, RhoE expression was induced by cisplatin, a DNA damage-inducing agent. RhoE-expressing cells failed to accumulate cyclin D1 or p21(cip1) protein or to activate E2F-regulated genes in response to serum, although ERK, PI3-K/Akt, FAK, Rac, and cyclin D1 transcription was activated normally. The expression of proteins that bypass the retinoblastoma (pRb) family cell cycle checkpoint, including human papillomavirus E7, adenovirus E1A, and cyclin E, rescued cell cycle progression in RhoE-expressing cells. RhoE also inhibited Ras- and Raf-induced fibroblast transformation. These results indicate that RhoE inhibits cell cycle progression upstream of the pRb checkpoint.
Collapse
Affiliation(s)
- Priam Villalonga
- Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, 91 Riding House St., London W1W 7BS, United Kingdom
| | | | | | | |
Collapse
|
22
|
Villalonga P, López-Alcalá C, Chiloeches A, Gil J, Marais R, Bachs O, Agell N. Calmodulin prevents activation of Ras by PKC in 3T3 fibroblasts. J Biol Chem 2002; 277:37929-35. [PMID: 12151388 DOI: 10.1074/jbc.m202245200] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
We have shown previously (Villalonga, P., López- Alcalá, C., Bosch, M., Chiloeches, A., Rocamora, N., Gil, J., Marais, R., Marshall, C. J., Bachs, O., and Agell, N. (2001) Mol. Cell. Biol. 21, 7345-7354) that calmodulin negatively regulates Ras activation in fibroblasts. Hence, anti-calmodulin drugs (such as W13, trifluoroperazine, or W7) are able to induce Ras/ERK pathway activation under low levels of growth factors. We show here that cell treatment with protein kinase C (PKC) inhibitors abolishes W13-induced activation of Ras, Raf-1, and ERK. Consequently, PKC activity is essential for achieving the synergism between calmodulin inhibition and growth factors to activate Ras. Furthermore, whereas the activation of PKC by 12-O-tetradecanoylphorbol-13-acetate (TPA) does not induce Ras activation in 3T3 cells, activation is observed if calmodulin is simultaneously inhibited. This indicates that calmodulin is preventing Ras activation by PKC. Treatment of cells with epidermal growth factor receptor or platelet-derived growth factor receptor tyrosine kinase inhibitors does not abrogate the activation of Ras by calmodulin inhibition. This implies that epidermal growth factor receptor and platelet-derived growth factor receptor tyrosine kinase activities are dispensable for the activation of Ras by TPA plus W13, and, therefore, Ras activation is not a consequence of the transactivation of those receptors by the combination of the anti-calmodulin drug plus TPA. Furthermore, K-Ras, the isoform previously shown to bind to calmodulin, is the only one activated by TPA when calmodulin is inhibited. These data suggest that direct interaction between K-Ras and calmodulin may account for the inability of PKC to activate Ras in 3T3 fibroblasts. In vitro experiments showed that the phosphorylation of K-Ras by PKC was inhibited by calmodulin, suggesting that calmodulin-dependent modulation of K-Ras phosphorylation by PKC could be the mechanism underlying K-Ras activation in fibroblasts treated with TPA plus W13.
Collapse
Affiliation(s)
- Priam Villalonga
- Departament de Biologia Cel.lular i Anatomia Patològica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain
| | | | | | | | | | | | | |
Collapse
|
23
|
Abstract
Ras activation induces a variety of cellular responses that depend on the specific activated effector, the intensity and amplitude of its activation, and the cellular type. Transient activation followed by a sustained but low signal of the Ras/Raf/MEK/ERK pathway is a common feature of cell proliferation in many systems. On the contrary, sustained, high activation is linked with either senescence or apoptosis in fibroblasts and to differentiation in neurones and PC12 cells. The temporal regulation of the pathway is relevant and not only depends on the specific receptor activated but also on the presence of diverse modulators of the pathway. We review here evidence showing that calcium (Ca(2+)) and calmodulin (CaM) are able to regulate the Ras/Raf/MEK/ERK pathway. CaM-binding proteins (CaMBPs) as Ras-GRF and CaM-dependent protein kinase IV (CaMKIV) positively modulate ERK1/2 activation induced by either NGF or membrane depolarisation in neurones. In fibroblasts, CaM binding to EGF receptor and K-Ras(B) may be involved in the downregulation of the pathway after its activation, allowing a proliferative signalling.
Collapse
Affiliation(s)
- Neus Agell
- Departament de Biologia Cel.lular i Anatomia Patològica, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Facultat de Medicina. Universitat de Barcelona, C/Casanova, 143, 08036 Barcelona, Spain.
| | | | | | | |
Collapse
|
24
|
Tebar F, Villalonga P, Sorkina T, Agell N, Sorkin A, Enrich C. Calmodulin regulates intracellular trafficking of epidermal growth factor receptor and the MAPK signaling pathway. Mol Biol Cell 2002; 13:2057-68. [PMID: 12058069 PMCID: PMC117624 DOI: 10.1091/mbc.01-12-0571] [Citation(s) in RCA: 69] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
The epidermal growth factor receptor (EGFR) is a member of the tyrosine kinase receptor family involved in signal transduction and the regulation of cellular proliferation and differentiation. It is also a calmodulin-binding protein. To examine the role of calmodulin in the regulation of EGFR, the effect of calmodulin antagonist, W-13, on the intracellular trafficking of EGFR and the MAPK signaling pathway was analyzed. W-13 did not alter the internalization of EGFR but inhibited its recycling and degradation, thus causing the accumulation of EGF and EGFR in enlarged early endosomal structures. In addition, we demonstrated that W-13 stimulated the tyrosine phosphorylation of EGFR and consequent recruitment of Shc adaptor protein with EGFR, presumably through inhibition of the calmodulin-dependent protein kinase II (CaM kinase II). W-13-mediated EGFR phosphorylation was blocked by metalloprotease inhibitor, BB94, indicating a possible involvement of shedding in this process. However, MAPK activity was decreased by W-13; dissection of this signaling pathway showed that W-13 specifically interferes with Raf-1 activity. These data are consistent with the regulation of EGFR by calmodulin at several steps of the receptor signaling and trafficking pathways.
Collapse
Affiliation(s)
- Francesc Tebar
- Departament de Biologia Cel.lular, Facultat de Medicina, Institut d'Investigacions August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain 08036
| | | | | | | | | | | |
Collapse
|
25
|
Villalonga P, López-Alcalá C, Bosch M, Chiloeches A, Rocamora N, Gil J, Marais R, Marshall CJ, Bachs O, Agell N. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling. Mol Cell Biol 2001; 21:7345-54. [PMID: 11585916 PMCID: PMC99908 DOI: 10.1128/mcb.21.21.7345-7354.2001] [Citation(s) in RCA: 164] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Activation of Ras induces a variety of cellular responses depending on the specific effector activated and the intensity and amplitude of this activation. We have previously shown that calmodulin is an essential molecule in the down-regulation of the Ras/Raf/MEK/extracellularly regulated kinase (ERK) pathway in cultured fibroblasts and that this is due at least in part to an inhibitory effect of calmodulin on Ras activation. Here we show that inhibition of calmodulin synergizes with diverse stimuli (epidermal growth factor, platelet-derived growth factor, bombesin, or fetal bovine serum) to induce ERK activation. Moreover, even in the absence of any added stimuli, activation of Ras by calmodulin inhibition was observed. To identify the calmodulin-binding protein involved in this process, calmodulin affinity chromatography was performed. We show that Ras and Raf from cellular lysates were able to bind to calmodulin. Furthermore, Ras binding to calmodulin was favored in lysates with large amounts of GTP-bound Ras, and it was Raf independent. Interestingly, only one of the Ras isoforms, K-RasB, was able to bind to calmodulin. Furthermore, calmodulin inhibition preferentially activated K-Ras. Interaction between calmodulin and K-RasB is direct and is inhibited by the calmodulin kinase II calmodulin-binding domain. Thus, GTP-bound K-RasB is a calmodulin-binding protein, and we suggest that this binding may be a key element in the modulation of Ras signaling.
Collapse
Affiliation(s)
- P Villalonga
- Departament de Biologia Cellular i Anatomia Patològica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
The elements of the cell cycle regulatory machinery activated by the oncogenic form of Ras, [Lys61]N-Ras, have been analysed in NIH3T3 cells. We demonstrate that [Lys61]N-Ras expression is able to induce full cdk4 activation. As already reported, oncogenic Ras expression was sufficient to induce cyclin D1 and p21cip1 expression and their association with cdk4. Furthermore, serum-starved [Lys61]N-Ras NIH3T3 cells showed nuclear accumulation of cyclin D1 and cdk4 not observed in serum-starved NIH3T3 cells. This accumulation of cdk4 into the cell nucleus observed in serum-starved [Lys61]N-Ras NIH3T3 cells was inhibited by a microinjection of neutralizing anti-Ras antibodies. Thus, active [Lys61]N-Ras was a sufficient signal to induce nuclear accumulation of cyclin D1/cdk4, leading to its full activation. Transfection of [Lys61]N-Ras NIH3T3 cells with an inactive form of MEK or their treatment with PD 98059, showed that nuclear translocation of cdk4 was MEK dependent. Interestingly, cells constitutively expressing [Lys61]N-Ras did not inactivate pRb and did not proliferate in the absence of serum. This may be due to the fact that although association of cdk2 with cyclin E and the translocation of those complexes to the nucleus were achieved, [Lys61]N-Ras expression was not sufficient to induce cdk2 activation. The high levels of p27(kip1) that were found in cyclin E/cdk2 complexes may be responsible for the inability of oncogenic Ras to activate this kinase. In consequence, oncogenic alterations that lead to a decrease in p27kip1 bound to cyclin E may cooperate with Ras to induce full cdk2 activation, pRb inactivation and thus cell proliferation.
Collapse
Affiliation(s)
- P Villalonga
- Department de Biologia Cellular i Anatomia Patològica, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Facultat de Medicina, Universitat de Barcelona, Spain
| | | | | | | |
Collapse
|
27
|
Sotorra O, Villalonga P, Ribera E, Mateo C, Castro M, Juste C. [Acute retinal necrosis caused by varicella zoster virus]. Enferm Infecc Microbiol Clin 1995; 13:130-1. [PMID: 7711128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|